2022年4月13日 · Although reconstructive techniques are increasingly used to treat mitral valve disease, mitral valve replacement (MVR) remains the only alternative in all pathologies not amenable to repair. In the case of redo MVR, which can be required for different reasons, the question is what options exist today and what are the outcomes.

2021年8月28日 · Redo mitral valve surgery is required in up to one‐third of patients and is associated with significant mortality and morbidity. Valve‐in‐valve transcatheter mitral valve replacement (ViV TMVR) is less invasive and could be considered in …

Results: 305 patients underwent redo MVr (n = 48) or MVR (n = 257) after prior mitral valve repair. Concomitant procedures included tricuspid valve repair or replacement (23%), aortic valve replacement (6%), and coronary artery bypass grafting (4%), with no differences between cohorts. 18% were performed via right mini-thoracotomy (24% MVr vs ...

The aim of this study was to investigate the overall outcome of adult patients undergoing redo-mitral valve replacement (redo-MVR) at our institution. Forty-nine patients (24 males) underwent redo-MVR with either bioprosthetic (n = 24) or mechanical ...

Valve-in-valve transcatheter mitral valve replacement (ViV TMVR) is less invasive and could be considered in those at prohibitive surgical risk. The aim of this study was to investigate the overall outcome of adult patients undergoing redo-mitral valve replacement (redo-MVR) at our institution.

2022年4月13日 · Objectives: Long-term echocardiographic reports on mitral valve (MV) porcine xenograft bioprosthesis (Epic™) are lacking and post-reintervention outcomes of failed Epic™ are unknown. We aimed to...

2014年8月14日 · Redo cardiac surgery represents a clinical challenge due to a higher rate of perioperative morbidity and mortality. Mitral valve (MV) reoperations can particularly be demanding in patients with patent coronary grafts, previous aortic valve replacement, calcified aorta or complications following a previous operation (abscesses, leaks or thrombosis).

The rising preference for percutaneous mitral valve-in-valve replacement (ViV TMVR) over redo surgical mitral valve replacement (MVR) is primarily due to its reduced bleeding risk. This report details a bloodless redo MVR performed for mitral stenosis post-ViV TMVR.

2022年3月1日 · We aimed To evaluate the in-hospital outcomes and associated risk factors for mortality and morbidity after re-operative mitral valve replacement in patients with initial rheumatic heart disease.

mitral valve disease, mitral valve replacement (MVR) remains the only alternative in all pathologies not amenable to repair. In the case of redo MVR, which can be required for different reasons, the question is what options exist today and what are the outcomes. In fact, data being useful to answer these questions is rare and it